Canada markets close in 4 hours 9 minutes

Bio-Rad Laboratories Inc (BUWA.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
265.90-4.20 (-1.55%)
As of 04:58PM CEST. Market open.
Full screen
Previous Close270.10
Open266.90
Bid266.80 x 0
Ask271.10 x 0
Day's Range265.90 - 266.90
52 Week Range246.10 - 381.40
Volume0
Avg. Volume0
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Bio-Rad Reports First-Quarter 2024 Financial Results

    HERCULES, Calif., May 07, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2024.

  • Business Wire

    Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference

    HERCULES, Calif., May 01, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Operating Officer Andy Last and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 2:05 PM Eastern Time (11:05 AM Pacific Time).

  • Business Wire

    Bio-Rad Announces Life Science Group Management Changes

    HERCULES, Calif., April 26, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice President and President of the Life Science Group, effective May 1, 2024. He succeeds Dr. Simon May, who has announced his decision to leave the company to pursue another professional opportunity.